marginally significantP = .07
Beyond classification of PDAC vs controls, our analysis also exposed a marginally significant elevation in the PDAC score in patients with lymph node metastasis in patients with PDAC ( P = .07) ( Figure 1 F ).
Beyond classification of PDAC vs controls, our analysis also exposed a marginally significant elevation in the PDAC score in patients with lymph node metastasis in patients with PDAC ( P = .07) ( Figure 1 F ).